Registry for diabetes patients in specialized care
DIABASE; Diabetes Mellitus Registry in Second Care
This study is collecting information from adults with type 1 and type 2 diabetes at ZGT Hospital to see how well current diabetes care and devices are working in real life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ziekenhuisgroep Twente Academic / other |
| Locations | 1 site (Almelo, Overijssel) |
| Trial ID | NCT05584293 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and analyze real-world data from patients with type 1 and type 2 diabetes who are receiving care at the ZGT Hospital. By building a comprehensive registry, the study seeks to improve individual patient care through insights gained from clinical outcomes and medical device usage. Patients aged 18 and older who provide informed consent will be included, while those with severe general diseases or mental disorders will be excluded. The focus is on understanding the effectiveness of current diabetes management strategies in a real-world setting.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with type 1 or type 2 diabetes who are visiting the outpatient clinic at ZGT Hospital.
Not a fit: Patients with severe general diseases or mental disorders that prevent participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to enhanced personalized care and improved health outcomes for diabetes patients.
How similar studies have performed: Other studies utilizing real-world data registries for diabetes management have shown promise in improving patient care, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with type 1 or type 2 diabetes * Patients aged 18 years or older * Patients visiting the outpatient clinic internal medicine in the ZGT Hospital * Written informed consent Exclusion Criteria: * Severe general diseases or mental disorders making the participation in the study impossible
Where this trial is running
Almelo, Overijssel
- Ziekenhuisgroep Twente — Almelo, Overijssel, Netherlands (Recruiting)
Study contacts
- Study coordinator: Thomas Urgert, MSc
- Email: t.urgert@zgt.nl
- Phone: +31887083236
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.